Abstract

Novel quinoline-4-carboxamide derivatives was synthesized as acetylcholinesterase inhibitors. In the amidation reaction in addition of target compounds a bis-N-acylurea were also obtained. 5f with the lowest docking energy, exhibited the most anticholinesterase inhibitory potency. A new series of N-(1-benzylpiperidin-4-yl) quinoline-4-carboxamide derivatives was designed and synthesized as potential acetylcholinesterase inhibitors. The compounds were characterized by nuclear magnetic resonance, infrared and mass spectrometry. In the amidation reaction in addition of target compounds 5a -5 h, a bis-N-acylurea were also obtained especially when we added more carbonyldiimidazole (CDI) for the completion of the reaction. Although docking study of these compounds predicted that they will inhibit acetylcholinesterase (AChE) protein strongly and more than the reference drugs, the in vitro evaluation of the quinolines 5a -5 h revealed that most of them had moderate activity toward AChE. The results showed that there is a correlation between anticholinesterase inhibitory potency and docking energy of compounds. Among these compounds, 5f with the lowest docking energy, exhibited the most anticholinesterase inhibitory potency. Molecular dynamics simulation and molecular docking studies of compound 5f into the binding site of acetylcholinesterase exhibited the probable interactions of 5f with the binding site of acetylcholinesterase.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.